2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review

34Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Amyloidosis is a protein folding disease that causes organ injuries and even death. In humans, 42 proteins are now known to cause amyloidosis. Some proteins become amyloidogenic as a result of a pathogenic variant as seen in hereditary amyloidoses. In acquired forms of amyloidosis, the proteins form amyloid in their wild-type state. Four types (serum amyloid A, transthyretin, apolipoprotein A-IV, and β2-macroglobulin) of amyloid can occur either as acquired or as a mutant. Iatrogenic amyloid from injected protein medications have also been reported and AIL1RAP (anakinra) has been recently found to involve the kidney. Finally, the mechanism of how leukocyte cell–derived chemotaxin 2 (ALECT2) forms amyloid remains unknown. This article reviews the amyloids that involve the kidney and how they are typed.

Cite

CITATION STYLE

APA

Leung, N., & Nasr, S. H. (2024, September 1). 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review. American Journal of Kidney Diseases. W.B. Saunders. https://doi.org/10.1053/j.ajkd.2024.01.530

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free